Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL785686 | 0.92 | BDKRB1 (0.59) | F10BDKRB1 | |
| SCHEMBL783741 | 0.92 | BDKRB1 (0.59) | F10BDKRB1 | |
| SCHEMBL784115 | 0.91 | ALDH1A1 (0.44) | F10BDKRB1 | |
| SCHEMBL785225 | 0.88 | MEN1 (0.52) | BDKRB1 | |
| SCHEMBL784388 | 0.86 | BDKRB1 (0.52) | F10BDKRB1 | |
| SCHEMBL784836 | 0.86 | BDKRB1 (0.45) | BDKRB1 | |
| SCHEMBL785272 | 0.84 | BDKRB1 (0.47) | BDKRB1 | |
| SCHEMBL784809 | 0.84 | ALDH1A1 (0.44) | BDKRB1 | |
| SCHEMBL784261 | 0.83 | ALDH1A1 (0.43) | F10BDKRB1 | |
| SCHEMBL777867 | 0.83 | ALDH1A1 (0.43) | F10BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680159-B2 | Bradykinin 1 receptor modulating compounds | GRUENENTHAL GMBH (DE) | 2014-03-25 | — | — | US | claimed |
| US-20120071461-A1 | Substituted Benzamide Compounds | GRUENENTHAL GMBH (DE) | 2012-03-22 | — | — | US | claimed |
| US-8680159-B2 | Bradykinin 1 receptor modulating compounds | GRUENENTHAL GMBH (DE) | 2014-03-25 | — | — | US | disclosed |
| US-20120071461-A1 | Substituted Benzamide Compounds | GRUENENTHAL GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071461-A1 | Substituted Benzamide Compounds | BDKRB1, BDKRB2, HRH2 | F10 524/4885BDKRB1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.